Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma.
Journal Of Cancer
Hong, Mi Jeong MJ; Park, Ji Eun JE; Lee, Shin Yup SY; Lee, Jang Hyuck JH; Choi, Jin Eun JE; Kang, Hyo-Gyoung HG; Do, Sook Kyung SK; Jeong, Ji Yun JY; Shin, Kyung Min KM; Lee, Won Ki WK; Seok, Yangki Y; Choi, Sun Ha SH; Lee, Yong Hoon YH; Seo, Hyewon H; Yoo, Seung Soo SS; Lee, Jaehee J; Cha, Seung Ick SI; Kim, Chang Ho CH; Park, Jae Yong JY
Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients.
Pharmacogenomics And Personalized Medicine
Park, Ji Eun JE; Hong, Mi Jeong MJ; Lee, Shin Yup SY; Lee, Jang Hyuck JH; Choi, Jin Eun JE; Kang, Hyo-Gyoung HG; Do, Sook Kyung SK; Jeong, Ji Yun JY; Shin, Kyung Min KM; Lee, Won Kee WK; Choi, Sun Ha SH; Lee, Yong Hoon YH; Seo, Hye Won HW; Yoo, Seung Soo SS; Lee, Jaehee J; Cha, Seung Ick SI; Kim, Chang Ho CH; Park, Jae Yong JY
A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
Oncotarget
Hong, Mi Jeong MJ; Lee, Shin Yup SY; Choi, Jin Eun JE; Jin, Cheng Cheng CC; Kang, Hyo Jung HJ; Baek, Sun Ah SA; Lee, So Yeon SY; Shin, Kyung Min KM; Jeong, Ji Yun JY; Lee, Won Kee WK; Yoo, Seung Soo SS; Lee, Jaehee J; Cha, Seung Ick SI; Kim, Chang Ho CH; Son, Ji Woong JW; Park, Jae Yong JY